Table 1.
Baseline Characteristics of UKBioBank Participants With Long-term ABx Medication
| No ABx PPI (n = 496,577) | Long-term ABx (n = 594) | P value | |
|---|---|---|---|
| Characteristics | |||
| Age (y) | 56.6 ± 8.1 | 59.9 ± 8.1 | .369 |
| Women (%) | 54 | 55 | .716 |
| BMI (kg/m2) | 27.4 ± 4.8 | 28.2 ± 5.8 | .001 |
| Charlson comorbidity index (units) | 1.4 ± 1.0 | 1.7 ± 1.2 | <.0001 |
| APRI (units) | 0.28 ± 0.51 | 0.29 ± 0.22 | .473 |
NOTE. Statistical significance was determined by unpaired Student t test or χ2 test. All significant covariates were included in the multivariate model.